Eustasius Musenge to Autoantibodies
This is a "connection" page, showing publications Eustasius Musenge has written about Autoantibodies.
Connection Strength
0,436
-
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord. 2015 May 29; 16:130.
Score: 0,120
-
HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther. 2011; 13(5):R160.
Score: 0,093
-
Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm. 2010; 2010:158514.
Score: 0,089
-
The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol. 2010 Jun; 29(6):615-8.
Score: 0,083
-
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm. 2013; 2013:183653.
Score: 0,026
-
Exaggerated circulating Th-1 cytokine response in early rheumatoid arthritis patients with nodules. Cytokine. 2012 Nov; 60(2):561-4.
Score: 0,025